LeJeune Puetz Investment Counsel’s Bristol-Myers Squibb BMY Stock Holding History

LeJeune Puetz Investment Counsel’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$939K	Buy	13,544 +781	+6%	+$55.1K	0.34%	88
2022 Q4	$918K	Hold	12,763	–	–	0.34%	86
2022 Q3	$907K	Hold	12,763	–	–	0.37%	82
2022 Q2	$982K	Sell	12,763 -695	-5%	-$52.9K	0.38%	81
2022 Q1	$982K	Hold	13,458	–	–	0.34%	89
2021 Q4	$839K	Buy	13,458 +175	+1%	+$10.3K	0.28%	93
2021 Q3	$786K	Buy	13,283 +800	+6%	+$52.7K	0.29%	94
2021 Q2	$834K	Buy	12,483 +375	+3%	+$24.5K	0.31%	91
2021 Q1	$764K	Hold	12,108	–	–	0.3%	90
2020 Q4	$751K	Hold	12,108	–	–	0.32%	86
2020 Q3	$730K	Hold	12,108	–	–	0.36%	81
2020 Q2	$712K	Sell	12,108 -1,885	-13%	-$113K	0.37%	79
2020 Q1	$780K	Buy	13,993 +1,950	+16%	+$119K	0.46%	68
2019 Q4	$773K	Buy	12,043 +880	+8%	+$50.4K	0.36%	83
2019 Q3	$566K	Buy	11,163 +250	+2%	+$11.8K	0.29%	93
2019 Q2	$495K	Buy	+10,913	New	+$508K	0.26%	98

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

LeJeune Puetz Investment Counsel's BMY Position: Q1 2023 in Review

LeJeune Puetz Investment Counsel increased its Bristol-Myers Squibb (BMY) stake by 6.1% in Q1 2023, buying an estimated $55.1K and bringing the position to 13,544 shares worth $939K. The position accounts for 0.34% of the portfolio, ranked #88.

LeJeune Puetz Investment Counsel first reported a position in BMY in Q2 2019 and has held it in 16 quarters since. The position peaked at $982K in Q2 2022. 2,541 funds tracked by Wall St. Rank hold BMY as of Q1 2023.

LeJeune Puetz Investment Counsel held 13,544 shares of Bristol-Myers Squibb worth $939K as of Q1 2023.
LeJeune Puetz Investment Counsel bought 781 Bristol-Myers Squibb shares in Q1 2023, an estimated $55.1K.
Bristol-Myers Squibb made up 0.34% of LeJeune Puetz Investment Counsel's portfolio in Q1 2023, its #88 holding.
LeJeune Puetz Investment Counsel first reported a position in Bristol-Myers Squibb in Q2 2019 and has held it in 16 quarters since.
LeJeune Puetz Investment Counsel's Bristol-Myers Squibb position peaked at $982K in Q2 2022.
2,541 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2023.

Based on LeJeune Puetz Investment Counsel's 13F filing for Q1 2023, filed 3 May 2023.